Imbalance of B-Cell Subpopulations in the Microenvironment of Sarcoidosis or Lung Cancer.
Agata RaniszewskaIwona KwiecieńElżbieta RutkowskaJoanna BednarekRafał SokołowskiPiotr MikluszPiotr RzepeckiKarina Jahnz-RozykPublished in: Cells (2024)
Although the role of T lymphocytes in sarcoidosis (SA) and lung cancer (LC) is quite well reported, the occurrence of B cells in disease microenvironments may suggest their potential role as natural modifiers of the immune response. The aim of this study was to investigate the B-cell profile and lymphocyte-related hematological parameters between patients with SA, LC and healthy controls (HCs). The cells were assessed by flow cytometry and a hematological analyzer in peripheral blood (PB) and material from lymph nodes (LNs) obtained by the EBUS/TBNA method. We showed that in SA patients, there were higher percentages of naïve B and CD21low B cells and a lower percentage of class-switched memory B cells than LC patients in LNs. We observed a higher median proportion of non-switched memory and transitional B cells in the PB of SA patients than in LC patients. We noticed the lowest median proportion of class-switched memory B cells in the PB from SA patients. LC patients had a higher percentage of RE-LYMP and AS-LYMP than SA patients. Our study presented a different profile of B-cell subpopulations in SA and LC patients, distinguishing dominant subpopulations, and showed the relocation from distant compartments of the circulation to the disease microenvironment, thus emphasizing their role.
Keyphrases
- end stage renal disease
- immune response
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- stem cells
- lymph node
- peripheral blood
- patient reported outcomes
- early stage
- risk assessment
- cell death
- dendritic cells
- induced apoptosis
- endoplasmic reticulum stress
- liquid chromatography
- cell cycle arrest